Centre for Population & Health Sciences, University of Glasgow, UK.
Clin Endocrinol (Oxf). 2011 Jan;74(1):97-103. doi: 10.1111/j.1365-2265.2010.03921.x.
Seventy per cent of postmenopausal women suffer from hot flushes causing significant morbidity in 25%. Oestrogen replacement provides symptom relief, but its use has declined following safety issues and there is, as yet, no good alternative. Pathophysiology is poorly understood, but one proposed mechanism is altered peripheral vascular reactivity. It has recently been suggested that the presence of flushing may be a marker of underlying cardiovascular risk.
To measure (i) peripheral vascular reactivity in subcutaneous vessels (ii) routine and novel cardiovascular risk factors in postmenopausal women who flush, and compare results to a matched group of women who do not flush.
Thirty-two postmenopausal women with at least 20 flushes/week and 14 nonflushing postmenopausal women were recruited. Cutaneous microvascular perfusion was measured using laser Doppler imaging, and endothelial function was assessed by iontophoresis (administration of vasoactive agents through the skin by an electric current) of acetylcholine [Ach] (endothelial-dependent) and sodium nitroprusside [SNP] (endothelial independent). Blood samples for risk factors were taken following vascular assessment.
Both study groups were well matched demographically. The response of the subcutaneous vessels was greater in women who flushed than those who did not, following administration of both the endothelium-dependent and independent vasodilators, (ACh, P ≤ 0·001, SNP, P = 0·001, 2-way anova). By contrast, levels of High Density Lipoprotein (HDL)-cholesterol and ApoA1 were significantly lower in the flushing women compared with the control women (P = 0·02 and 0·002, respectively), and levels of inter-cellular adhesion molecule-1 (ICAM-1) were higher (P = 0·03), findings robust to adjustment for confounders, suggesting an adverse cardiovascular risk profile.
These results confirm a better vascular response in women but paradoxically, such women appear to have worse (not better) cardiovascular disease risk factors in particular lower HDL-cholesterol but also higher non-HDL-c to HDL-c ratio and increased ICAM-1. Further studies are needed to assess vascular risk factors in women who flush.
70%的绝经后妇女患有热潮红,其中 25%有明显的发病率。雌激素替代治疗可以缓解症状,但由于安全性问题,其使用已经减少,而且目前还没有很好的替代方法。发病机制了解甚少,但提出的一种机制是外周血管反应性改变。最近有人提出,潮红的存在可能是潜在心血管风险的标志物。
测量(i)有至少 20 次/周热潮红的绝经后妇女的皮下血管外周血管反应性,以及(ii)与无热潮红的绝经后妇女的常规和新型心血管危险因素,并将结果与无热潮红的绝经后妇女进行比较。
招募了 32 名至少每周有 20 次热潮红的绝经后妇女和 14 名无热潮红的绝经后妇女。使用激光多普勒成像测量皮肤微血管灌注,通过电流将血管活性药物(乙酰胆碱[Ach]和硝普钠[SNP])经皮导入(离子电渗疗法)评估内皮功能(内皮依赖性和内皮独立)。血管评估后采集危险因素血样。
两组研究对象在人口统计学上匹配良好。与无热潮红的妇女相比,有热潮红的妇女在给予内皮依赖性和非依赖性血管扩张剂后,皮下血管的反应性更大(Ach,P ≤ 0·001,SNP,P = 0·001,2 路方差分析)。相比之下,潮红妇女的高密度脂蛋白(HDL)-胆固醇和载脂蛋白 A1 水平明显低于对照组妇女(P = 0·02 和 0·002),细胞间黏附分子-1(ICAM-1)水平较高(P = 0·03),这些发现与混杂因素调整后仍然一致,表明存在不良的心血管风险特征。
这些结果证实了女性血管反应性更好,但矛盾的是,这样的女性似乎有更差(而不是更好)的心血管疾病危险因素,特别是 HDL-胆固醇较低,但非 HDL-c 与 HDL-c 的比值较高,以及 ICAM-1 增加。需要进一步研究来评估有热潮红的女性的血管危险因素。